Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2021

View Archived Issues

Novel series of 5,5-fused bicyclic PRMT5 inhibitors as potential anticancer therapeutics

Phase II results of suvratoxumab to prevent S. aureus ventilator-associated pneumonia

C4 selects CFT-8919 for progression into IND-enabling studies

The University of Pennsylvania describes fibronectin-targeting chimeric antigen receptors

AXL oncogene inhibitors discovered at Jiangsu Chia Tai Tianqing Pharmaceutical Group

Dual GLP-1/GCGR agonists synthesized at Dongguan Hec Biological Medicine Research & Development

Oncobix divulges mutant ALK/mutant EGFR inhibitors

REVOLUTION Medicines patents RAS inhibitors

Beclin-1 implicated in diabetic cardiomyopathy

FDA accepts IND application for LY-3819469

Oncorus announces development plans for its novel synthetic vRNA immunotherapy candidates

Gene signature governs anti-plaque microglia in AD

China NMPA approves CTA for phase IIb trial of AM-006 in Parkinson's disease

Activation of MT2 reduces cardiac I/R injury in prediabetic rats

Topical bevacizumab-800CW is safe for detecting esophageal lesions during NIR-FME

OSE's COVID-19 vaccine CoVepiT enters first-in-human study

DSMB recommends continuation of uniQure's phase I/II trial of AMT-130 in Huntington's disease

New biomarkers found to monitor disease progression in eosinophilic esophagitis

Preclinical data show AdCOVID neutralizes SARS-CoV-2 B.1.351 variant

Cystic Fibrosis Foundation awards support research at Metagenomi and Eloxx

AGT103-T HIV therapeutic enters first-in-human study

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.